Varian’s Smart Segmentation Tool Nets FDA Nod

Varian Medical Systems has received FDA 510(k) clearance for a “smart” radiotherapy treatment planning tool that will enable clinicians to significantly reduce the amount of time needed to plan advanced treatments, including intensity-modulated radiation therapy (IMRT) and image-guided radiation therapy (IGRT).
The new Smart Segmentation feature, which has been added to Varian’s Eclipse treatment planning product uses intelligent software to identify and outline organs and other structures within diagnostic images of the thorax and male pelvis. The tool can automatically identify all of the structures of interest in less than 45 seconds, according to its manufacturer.